The evidence for glutamine use in the critically-ill

Area of Science:

• Biochemistry
• Immunology
• Critical Care Medicine

Background:

• Glutamine plays a vital metabolic role, particularly in trauma and sepsis.
• Increased tissue demands in critical illness can exceed the body's natural glutamine production, leading to a conditional deficiency.

Purpose of the Study:

• To investigate the metabolic role of glutamine in trauma and sepsis.
• To examine the impact of parenteral glutamine supplementation on clinical outcomes in critically-ill patients.

Main Methods:

• Review of existing research on glutamine metabolism in critical illness.
• Analysis of studies evaluating parenteral glutamine provision and its effects.

Main Results:

• Evidence suggests a conditional glutamine deficiency in trauma and sepsis due to demand exceeding production.
• Parenteral glutamine supplementation is linked to improved immune function in the critically-ill.
• Supplementation is associated with enhanced survival rates from infection and better overall outcomes.

Conclusions:

• Conditional glutamine deficiency is a significant factor in critical illness.
• Restorative provision of parenteral glutamine can lead to improved clinical outcomes, including enhanced immune response and survival.